Health-related quality of life, palliative care needs and 12-month survival among patients with end stage renal disease in Uganda: protocol for a mixed methods longitudinal study

• Published in: BMC nephrology 2020-12, Vol.21 (1), p.531-531, Article 531
• Main Authors: Bagasha, Peace, Leng, Mhoira, Katabira, Elly, Petrova, Mila
• Format: Article
• Language: English
• Subjects: Care and treatment; Chronic [MeSH]; Chronic kidney failure; Data collection; Developing countries; Developing countries [MeSH]; Health aspects; Hemodialysis; Hospitals; Industrialized nations; Kidney diseases; Kidney failure; Kidney transplantation; LDCs; Longitudinal studies; Low income groups; Mixed methods; Mixed methods research; Mortality; Nephrology; Palliation; Palliative care; Palliative care [MeSH] renal Dialysis [MeSH]; Palliative treatment; Patient outcomes; Patients; Personal health; Quality of life; Quality of life [MeSH]; Socially handicapped; Study Protocol; Survival
• ISSN: 1471-2369; 1471-2369
• DOI: 10.1186/s12882-020-02197-7

The prevalence of chronic kidney disease is on the rise globally and in sub-Saharan Africa. Due to its "silent" nature, many patients often present with advanced disease. At this point options for care are often limited to renal replacement therapies such as hemodialysis and kidney transplantation. In resource limited settings, these options are associated with catastrophic expenditures and increased household poverty levels. Early palliative care interventions, if shown to ensure comparable quality of life (QoL), can significantly mitigate this by focusing care on comfort, symptom control and QoL rather than primarily on prolonging survival. A mixed methods longitudinal study, recruiting patients with End Stage Renal Disease (ESRD) on hemodialysis or conservative management and following them up over 12 months. The study aims are to: 1) measure and compare the health-related quality of life (HRQoL) scores of patients with ESRD receiving hemodialysis with those receiving conservative management, 2) measure and compare the palliative care needs and outcomes of patients in the two groups, 3) explore the impact of treatment modality and demographic, socio-economic and financial factors on QoL and palliative care needs and outcomes, 4) review patient survival over 12 months and 5) explore the patients' lived experiences. The Kidney Disease Quality Of Life Short Form version 1.3 (KDQOL-SF) will be used to measure HRQoL; the African Palliative Care Association Palliative care Outcome Score (APCA POS) and the Palliative care Outcome Score for renal symptoms (POS-S Renal) will be used to assess palliative care needs and outcomes; and semi-structured in-depth interviews to explore the patients' experiences of living with ESRD. Data collection will be carried out at 0, 3, 6, 9 and 12 months. To the best of our knowledge, no similar study has been conducted in sub-Saharan Africa. This will be an important step towards raising awareness of patients' need and preferences and the strengths and limitations of available health care services for ESRD in resource limited settings.